Risk Factors for Non-response to Hormonal Medical Therapy in Patients With Endometriosis

NCT06413381 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-08-01

No results posted yet for this study

Summary

Determine the proportion of patients with endometriosis unresponsive to medical therapy and to compare the clinical and ultrasonographic characteristics of this group of patients (study group) with the clinical and ultrasonographic characteristics of patients responsive to medical therapy (control group).

Conditions

  • Endometriosis

Sponsors & Collaborators

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-19
Primary Completion
2028-08-31
Completion
2029-11-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06413381 on ClinicalTrials.gov